Dexcom Inc (DXCM) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Dexcom Inc   (NASDAQ: DXCM)
 

Dexcom Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Dexcom Inc 's inventory turnover ratio sequentially decreased to 2.97 in the first quarter 2026, unsurprisingly, as the Dexcom Inc markets continue to deteriorate, and DXCM's faces growing challenges to bring down its inventories. Dexcom Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 123 days, from 115 days, in the Dec 31 2025 quarter.

Within Healthcare sector 131 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 288, from total ranking in the fourth quarter 2025 at 364.

DXCM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Dexcom Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DXCM Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 28.87 % 15.94 % 3.04 % 0.07 % -8.64 %
Y / Y Cost of Sales Growth -1.34 % 2.18 % 19.25 % 24.14 % 24.51 %
Inventory Turnover Ratio (TTM) 2.97 3.18 3.28 3.17 3.01
DXCM's Total Ranking # 288 # 364 # 364 # 364 # 364
Average inventory processing period 123 115 111 115 121
Seq. Inventory Growth 10.25 % 4.14 % 5.85 % 6.04 % -0.81 %
Seq. Cost of Sales Growth -5.77 % -1.89 % 1.92 % 4.7 % -2.4 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 52
Healthcare Sector # 132
Overall Market # 288

Inventory Turnover Ratio Statistics
High Average Low
11.09 4.73 2.33
(Dec 31 2018)   (Dec 31 2021)



DXCM Company Profile >> Back to DXCM Efficiency Comparisons >> Compare DXCM Inventory Turnover Ratio to its Competitors

Financial Statements
Dexcom Inc 's Inventories $ 694 Millions Visit DXCM's Balance sheet
Dexcom Inc 's Cost of Revenues TTM $ 1,854 Millions Visit DXCM's Income Statement
What are DXCM's Sales? Visit DXCM's Sales by Segment

Other Inventory Turnover Ratios
Dexcom Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
DXCM's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for DXCM's Competitors
Inventory Turnover Ratio for DXCM's Suppliers
Inventory Turnover Ratio for DXCM's Customers

You may also want to know
DXCM's Sales Growth Rates DXCM's Pe Price to earnings ratio DXCM's Receivables Turnover Ratio DXCM's Stock Quote
DXCM's Net Income Growth Rates DXCM's Ps Price to Sales ratio DXCM's Sales per Employee DXCM's Asset Turnover Ratio
DXCM's Net Margin DXCM's Pb Price to Book ratio DXCM's Financial Strength Ratios DXCM's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Puma Biotechnology Inc   7.19 $ 58.025  Millions$ 8  Millions
Fonar Corporation  7.06 $ 19.685  Millions$ 3  Millions
Carlisle Companies Incorporated  6.71 $ 3,206.100  Millions$ 478  Millions
Hims and Hers Health Inc   6.58 $ 670.000  Millions$ 102  Millions
Vanda Pharmaceuticals Inc   6.54 $ 12.682  Millions$ 2  Millions
Twist Bioscience Corporation  6.50 $ 196.251  Millions$ 30  Millions
Phathom Pharmaceuticals Inc   6.48 $ 30.871  Millions$ 5  Millions
Precision Optics Corporation Inc   6.47 $ 24.932  Millions$ 4  Millions
Nuo Therapeutics Inc   6.42 $ 1.331  Millions$ 0  Millions
Collegium Pharmaceutical Inc   6.41 $ 256.071  Millions$ 40  Millions
Veracyte Inc   6.05 $ 132.000  Millions$ 22  Millions
Kewaunee Scientific Corporation  5.98 $ 200.155  Millions$ 33  Millions
Adm Tronics Unlimited Inc   5.93 $ 1.992  Millions$ 0  Millions
Align Technology inc   5.81 $ 1,327.000  Millions$ 228  Millions
Transmedics Group Inc   5.71 $ 260.151  Millions$ 46  Millions
Opko Health Inc   5.69 $ 372.048  Millions$ 65  Millions
Avantor Inc   5.55 $ 4,447.000  Millions$ 801  Millions
Steris Plc  5.27 $ 3,309.400  Millions$ 628  Millions
Bristol myers Squibb Company  5.24 $ 14,324.000  Millions$ 2,735  Millions
Harrow Inc   5.11 $ 69.568  Millions$ 14  Millions
Integer Holdings Corporation  5.11 $ 1,365.000  Millions$ 267  Millions
Tactile Systems Technology Inc   5.08 $ 81.000  Millions$ 16  Millions
Integrated Biopharma Inc  4.96 $ 45.000  Millions$ 9  Millions
Ufp Technologies Inc   4.95 $ 436.000  Millions$ 88  Millions
Polomar Health Services, Inc.  4.79 $ 0.642  Millions$ 0  Millions
Henry Schein Inc   4.70 $ 9,209.000  Millions$ 1,959  Millions
Bionexus Gene Lab Corp   4.70 $ 4.191  Millions$ 1  Millions
Medinotec Inc   4.69 $ 4.864  Millions$ 1  Millions
West Pharmaceutical Services Inc   4.68 $ 2,052.000  Millions$ 439  Millions
Scilex Holding Company  4.48 $ 14.462  Millions$ 3  Millions

Date modified: 2026-08-29T17:16:48+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.